Federal · 119th Congress
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
Policy areaHealth
The Congressional Research Service has not published a summary of this measure.
Read the text of the bill →Sponsor
Cosponsors15
Eleanor Holmes NortonDU.S. Representative · At-Large · DC
Greg CasarDU.S. Representative · 35th District · TX
Lloyd DoggettDU.S. Representative · 37th District · TX
Pramila JayapalDU.S. Representative · 7th District · WA
Melanie A. StansburyDU.S. Representative · 1st District · NM
Mark TakanoDU.S. Representative · 39th District · CA
Rashida TlaibDU.S. Representative · 12th District · MI
Steve CohenDU.S. Representative · 9th District · TN
Jesús G. "Chuy" GarcíaDU.S. Representative · 4th District · IL
Ro KhannaDU.S. Representative · 17th District · CA
Jill N. TokudaDU.S. Representative · 2nd District · HI
Janice D. SchakowskyDU.S. Representative · 9th District · IL12 of 15
Other titles2
To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.Official Title as Introduced
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026Short Title(s) as Introduced
Legislative history2
Aug 13, 2026
HouseReferred to the House Committee on Energy and Commerce.
Aug 13, 2026
IntroducedIntroduced in House